PRF Technologies (PRFX) Current Assets (2019 - 2025)
PRF Technologies (PRFX) posted quarterly Current Assets of $4.4 million for Q4 2025, down 1.74% year-on-year from $4.4 million in Q4 2024, and up 11.31% on a QoQ basis from $3.9 million in Q2 2025.
PRF Technologies (PRFX) Current Assets (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Current Assets for 7 consecutive years, with $4.4 million the latest figure, recorded in Q4 2025.
- Quarterly Current Assets fell 1.74% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (down 1.74% YoY) and the FY2025 annual result came in at $4.4 million, down 1.74% from the prior year.
- Current Assets advanced to $4.4 million in Q4 2025 per PRFX's latest filing, from $3.9 million in the prior quarter.
- Over the last five years, Current Assets for PRFX reached as high as $21.3 million in Q1 2021 and fell as low as $371000.0 in Q4 2023.
- A 5-year average of $11.3 million and a median of $10.7 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets jumped 3413.12% — and 2023, when it sank 96.98%.
- Year by year, Current Assets stood at $19.0 million in 2021, then tumbled by 35.42% to $12.3 million in 2022, then plunged by 96.98% to $371000.0 in 2023, then jumped by 1093.53% to $4.4 million in 2024, then retreated by 1.74% to $4.4 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $4.4 million, $3.9 million, and $4.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.35 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Jun 30, 2024 | 2.99 Mn |
| Mar 31, 2024 | 5.25 Mn |
| Dec 31, 2023 | 371,000.00 |
| Sep 30, 2023 | 10.74 Mn |
| Jun 30, 2023 | 8.28 Mn |
| Mar 31, 2023 | 10.38 Mn |
| Dec 31, 2022 | 12.28 Mn |
| Sep 30, 2022 | 14.81 Mn |
| Jun 30, 2022 | 15.93 Mn |
| Mar 31, 2022 | 17.65 Mn |
| Dec 31, 2021 | 19.02 Mn |
| Sep 30, 2021 | 20.31 Mn |
| Jun 30, 2021 | 19.81 Mn |
| Mar 31, 2021 | 21.33 Mn |
| Dec 31, 2020 | 17.79 Mn |
| Jun 30, 2020 | 564,000.00 |
| Dec 31, 2019 | 972,000.00 |